Alexander Beadle
Science Writer
Alexander Beadle has been working as a freelance science writer since 2017 and has covered the cannabis industry for Analytical Cannabis since 2018. He has also written for our sister publication, Technology Networks, and the cannabis industry consultant firm Prohibition Partners, among others. Alexander holds an MChem in materials chemistry from the University of St Andrews, where he won a Chemistry Purdie Scholarship and conducted research into zeolite crystal growth mechanisms and the action of single-molecule transistors.
Latest Content From Alexander Beadle
Covid-19 Could Delay Cannabis Legalization in New York and Mexico
Pieces of cannabis legislation around the world now face significant delays due to fallout from the coronavirus pandemic.
VIEW
Which US States Have Kept Cannabis Businesses Open During Coronavirus Restrictions?
Analytical Cannabis breaks down the coronavirus-related rules cannabis companies must now adhere to by state.
VIEW
Cannabis Dispensaries Are Now Essential Businesses in California
Gov. Newsom has included cannabis retailers as “essential” under the official state policy.
VIEW
Zeroing in on the Entourage Effect
This finding casts doubt on proposed theories for a terpene-cannabinoid entourage effect.
VIEW
CBD-coronavirus Misinformation Is Already Here
As the coronavirus spreads around the world, CBD misinformation has followed.
VIEW
Are Biocontrol Solutions a Useful Tool for Cannabis Cultivators?
By avoiding the use of pesticides, some experts say, farmers may find their crops grow more vigorously.
VIEW
How Will Coronavirus Affect the Cannabis Industry?
The global spread of COVID-19 is set to cause widespread disruption to businesses, education systems, and public events around the world – and the legal cannabis industry will be no exception.
VIEW
UK's Health Service Urged to Consider New Medical Cannabis Guidance
The Medical Cannabis Clinicians Society says that medical cannabis is being unfairly denied to British patients.
VIEW
Low CBD Doses Help Half Seizure Rate in Children, Study Finds
The results come from a randomized double-blind clinical trial, which examined the efficacy and safety of CBD as an add-on treatment for children with Dravet syndrome.
Could a Cannabis Compound Beat Antibiotic Resistance?
A common cannabinoid might be the answer to combating drug-resistant superbugs, according to a new study.
VIEW